The Covid-19 Vaccination: Autoimmune Phenomenon Alopecia Areata
Studysummary This review discusses the development and rapid approval of COVID-19 vaccines and notes the observation of autoimmune disorders, such as alopecia areata, following vaccination; it provides no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document reports that COVID-19 vaccines, particularly mRNA vaccines and the adenovirus vector vaccine Covishield, may trigger autoimmune disorders such as alopecia areata in genetically predisposed individuals, with 84% of hair loss cases occurring within one month post-vaccination. The rapid development of these vaccines, which took 2-3 months instead of the usual 12-15 years, might have led to insufficient research on long-term effects, including autoimmune side effects. Alopecia areata, characterized by circular hair loss patches, is a significant side effect, affecting about 20% of patients post-infection. Treatments for vaccine-induced alopecia areata include immunosuppressants, corticosteroids, anti-inflammatory drugs, Minoxidil, and Betamethasone.
